|
Guaifenesin for Injection
» Guaifenesin for Injection contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of guaifenesin (C10H14O4).
Packaging and storage
Preserve in single-dose or in multiple-dose containers, and store at controlled room temperature.
Labeling
It meets the requirements for Labeling under Injections
Identification,
Infrared Absorption
Constituted solution
At the time of use, it meets the requirements for Constituted Solutions under Injections
Sterility
Bacterial endotoxins
Assay
Standard preparation
Dissolve an accurately weighed quantity of USP Guaifenesin RS in chloroform to obtain a solution having a known concentration of about 40 µg per mL.
Assay preparation
Constitute a container of Guaifenesin for Injection with a volume of warm (30
Procedure
Concomitantly determine the absorbances of the Standard preparation and the Assay preparation at the wavelength of maximum absorbance at about 276 nm, using chloroform to zero the instrument. Calculate the quantity, in mg, of guaifenesin (C10H14O4) in each mL of the constituted solution of Guaifenesin for Injection taken by the formula:
2.5(C / V)(AU / AS)
in which C is the concentration, in µg per mL, of USP Guaifenesin RS in the Standard preparation, V is the volume, in mL, of constituted solution taken to prepare the Assay preparation, and AU and AS are the absorbances of the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 3382
|